Anja Health names Jan Chen CEO

By AI, Created 6:01 PM UTC, June 04, 2026, /AGP/ – Anja Health has appointed stem cell banking veteran Jan Chen as chief executive officer, bringing 18 years of industry and family healthcare experience to the Los Angeles company. The move signals a push to expand access to cord blood, cord tissue, and placental tissue banking while deepening provider partnerships and family support.

Why it matters: - Jan Chen’s appointment gives Anja Health a CEO with deep stem cell banking experience and family healthcare expertise. - The move could help the company broaden access to newborn stem cell preservation and strengthen its relationships with healthcare providers. - Anja Health is positioning leadership experience as a key part of its growth strategy in a specialized medical services market.

What happened: - Anja Health announced Jan Chen as its new chief executive officer on June 4, 2026. - Chen joins the Los Angeles-based company after 18 years in stem cell banking and family healthcare services. - Anja Health provides cord blood, cord tissue, and placental tissue banking services. - Chen previously served as Head of International Sales at FamilyCord.

The details: - Chen has spent her career helping families preserve newborn stem cells and understand regenerative medicine. - Chen and her team have supported tens of thousands of families across North America. - Her work has involved close coordination with obstetricians, fertility specialists, surrogacy professionals, midwives, hospitals, and other healthcare providers. - At FamilyCord, Chen helped expand access to stem cell preservation programs for families across the United States and Canada. - Anja Health said Chen’s leadership will support continued growth in stem cell banking access, family education, and provider partnerships. - Anja Health partners with the Vitalant Cord Blood Stem Cell Laboratory. - The partnership combines personalized family support with laboratory expertise built through decades of blood and cellular therapy experience. - The company said the joint goal is to deliver a trusted and transparent stem cell preservation experience. - Kathryn Cross, founder of Anja Health, said Chen’s industry knowledge, leadership experience, and family focus make her a strong addition to the company. - Chen said she wants to help families access trusted information, quality services, and compassionate support during childbirth. - Chen also said she aims to build on Anja Health’s commitment to helping families preserve biological resources that may support future medical advances.

Between the lines: - Anja Health is leaning on experienced leadership to differentiate itself in a niche category where trust and education matter. - The company’s emphasis on family-focused support suggests it is targeting parents who want more guidance around newborn stem cell banking. - The Vitalant partnership also signals that laboratory credibility remains central to how Anja Health markets its service.

What’s next: - Chen will lead Anja Health as it works to expand stem cell banking access and deepen relationships with healthcare providers. - The company plans to keep focusing on family education and the customer experience under her leadership. - Anja Health is also expected to continue building on its laboratory partnership and transparent service model. - More information is available here.